乳腺癌放射治疗暴露对乳腺动脉钙化患病率的影响
这项横断面研究纳入2011年1月1日至2012年12月31日期间接受筛查性乳腺X线摄影的40-75岁女性1155例,评估乳腺放疗暴露是否影响乳腺动脉钙化(BAC)作为心血管疾病风险影像生物标志物的效用。222例(19.2%)有BAC,122例(10.6%)有放疗暴露史,放疗暴露组BAC患病率为32%(39例)。单变量分析显示放疗暴露与BAC存在关联(OR 2.18,95%CI 1.43-3.28,P=.0008),但多变量调整后该关联不再显著(OR 1.52,95%CI 0.95-2.40,P=.07)。作者认为乳腺放疗暴露似乎不影响BAC患病率,因此不影响其作为心血管疾病风险影像生物标志物的效用。
要点
- 放疗暴露组BAC患病率为32%(39/122),全组BAC患病率为19.2%(222/1155)。
- 单变量分析放疗暴露与BAC相关(OR 2.18,95%CI 1.43-3.28,P=.0008),多变量调整后不再显著(OR 1.52,95%CI 0.95-2.40,P=.07)。
- 作者认为放疗暴露似乎不影响BAC作为心血管疾病风险影像生物标志物的效用。
核心结论
- 作者认为乳腺放疗暴露似乎不影响乳腺X线摄影上BAC的患病率,因此不影响其作为心血管疾病风险影像生物标志物的效用。
研究设计与样本
- 横断面研究,纳入2011年1月1日至2012年12月31日期间接受筛查性乳腺X线摄影的40-75岁女性1155例,通过病历回顾提取乳腺癌放疗暴露及心血管疾病风险因素数据,并阅片评估BAC是否存在。
关键影像表现/征象
- 乳腺X线摄影上BAC表现为乳腺动脉钙化,全组1155例中222例(19.2%)存在BAC。
- 122例(10.6%)有放疗暴露史,其中39例(32%)存在BAC。
诊断标准与关键数值
- BAC以乳腺X线摄影上存在动脉钙化为判定依据。
- 单变量分析:放疗暴露组相比无放疗暴露组BAC的OR为2.18(95%CI 1.43-3.28,P=.0008)。
- 多变量调整年龄、体重指数、吸烟状态、高血压、2型糖尿病、他汀类药物使用及降压药物使用后,最大调整模型OR为1.52(95%CI 0.95-2.40,P=.07),未达统计学显著。
临床应用与阅片要点
- 作者认为放疗暴露似乎不影响BAC患病率,因此不影响其作为心血管疾病风险影像生物标志物的效用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Mammographic breast arterial calcification (BAC) is an emerging imaging biomarker of cardiovascular disease (CVD) risk in women. The purpose of this study was to assess if breast radiation therapy (RT) exposure impacts the screening utility of this imaging biomarker.
METHODS: This cross-sectional study included women ages 40-75 years who underwent index screening mammography between January 1, 2011 and December 31, 2012. Chart review was performed to extract data on the breast cancer RT exposure and CVD risk factors. Mammograms were reviewed for the presence of BAC. Multivariate logistic regression was used to examine breast RT exposure and BAC, with adjustment for age, body mass index, smoking status, hypertension, Type 2 diabetes, statin medication use, and antihypertensive medication use.
RESULTS: Of the 1155 women included in this analysis, 222 (19.2%) had mammographic evidence of BAC, 122 (10.6%) had a history of RT exposure, and 39 (32%) women with RT exposure had mammographic BAC. Women with breast RT exposure had higher odds of BAC compared to women without (odds ratio: 2.18, 95% CI: 1.43, 3.28; P-value = .0008). However, this association became non-significant after multivariable adjustment, with the maximally adjusted model demonstrating an odds ratio of 1.52 (95% CI: 0.95, 2.40; P-value = .07).
CONCLUSIONS: Our findings suggest that breast RT exposure does not impact the prevalence of mammographic BAC. Therefore, it does not affect its utility as an imaging biomarker of CVD risk.
ADVANCES IN KNOWLEDGE: This is the first observational study addressing the knowledge gap pertaining to the influence of breast RT exposure on BAC.
引用
- Ramin SK, Rubino J, Austin-Strohbehn JM, et al. The impact of breast cancer radiation therapy exposure on the prevalence of breast arterial calcification. Br J Radiol. 2024. PMID: 39235929. doi:10.1093/bjr/tqae182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。